Lipopolysaccharide (LPS) exposure differently affects allergic asthma exacerbations and its amelioration by intranasal curcumin in mice. Issue 2 (December 2015)

• Record Type: Journal Article
• Authors: Kumari, Asha; Dash, D.; Singh, Rashmi
• Is Part Of: Cytokine. Volume 76:Issue 2(2015)
• Page Start: 334
• Page End: 342
• Publication Date: 2015-12
• Subjects: Cytokines -- Periodicals; 571.844
• DOI: 10.1016/j.cyto.2015.07.022
• Languages: English
• ISSNs: 1043-4666

Abstract

<abstract xml:lang="en" abstract-type="author-highlights" id="ab005"> <title id="st005">Highlights</title> <sec> <p id="sp0005"> <list id="l0005"> <list-item id="o0005"> <label></label> <p id="p0005">Dose and schedule of LPS exposure determines asthma exacerbations.</p> </list-item> <list-item id="o0010"> <label></label> <p id="p0010">Lower dose of LPS exposure is better in exacerbating allergic asthma.</p> </list-item> <list-item id="o0015"> <label></label> <p id="p0015">Enhanced airway inflammations are dominated by eosinophils and neutrophils.</p> </list-item> <list-item id="o0020"> <label></label> <p id="p0020">Th2 cytokine and IgE levels are enhanced after LPS exposure.</p> </list-item> <list-item id="o0025"> <label></label> <p id="p0025">Intranasal curcumin is better in ameliorating the exacerbations than dexamethasone.</p> </list-item> </list> </p> </sec> </abstract>